BJMO - volume 7, issue 4, september 2013
T. Feys MBA, MSc
From May 31st till June 4th, Chicago again hosted the annual meeting of the American Society of Clinical Oncology (ASCO). The ASCO Annual Meeting brought together over 25,000 oncology professionals from a broad range of specialties. This summary does not aim at giving a complete overview of the meeting but will briefly touch on twenty key studies presented at the meeting. All abstracts cited in this summary can be consulted in more detail at the ASCO website (am.asco.org).
(BELG J MED ONCOL 2013;7(4):127–32)
Read moreBJMO - volume 7, issue 3, july 2013
T. Feys MBA, MSc, P. Specenier MD, PhD
Overview of Belgian reimbursement news.
(BELG J MED ONCOL 2013;7(3):101)
Read moreBJMO - volume 7, issue 2, may 2013
T. Feys MBA, MSc, P. Specenier MD, PhD
Overview of Belgian reimbursement news.
(BELG J MED ONCOL 2013;7(2):68)
Read moreBJMO - volume 7, issue 2, may 2013
T. Feys MBA, MSc
The American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium 2013 held from the 14th – 16th of February, 2013, in Orlando, Florida, focused on multidisciplinary approaches to the prevention, screening, evaluation, and management of genitourinary (GU) cancers.
(BELG J MED ONCOL 2013;7(2):60–62)
Read moreBJMO - volume 7, issue 2, may 2013
T. Feys MBA, MSc
From the 24th till the 26th of January, San Francisco was the setting for the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium 2013. The meeting, cosponsored by ASCO, ASTRO and SSO, again focused on multidisciplinary approaches to the prevention, screening, evaluation, and management of gastrointestinal (GI) cancers.
(BELG J MED ONCOL 2013;7(2):57–59)
Read moreBJMO - volume 7, issue 1, february 2013
T. Feys MBA, MSc, J. De Grève MD, PhD
2012 has been a rich year in progress on cancer care. Many studies highlighted this year capitalised on the growing insight into the complexity of cancer to develop sophisticated treatment approaches, including combinations of targeted drugs for difficult-to-treat cancers and expanded use of targeted drugs to multiple forms of cancer sharing the same genetic alteration. This article is based on the clinical cancer advances 2012 article published by the American Society of Clinical Oncology and lists the most important advances made in the different fields of oncology that are most likely to impact daily clinical practice.1
(BELG J MED ONCOL 2013;7:10–14)
Read moreBJMO - volume 7, issue 1, february 2013
T. Feys MBA, MSc, J. De Grève MD, PhD
From December 4th-8th 2012, San Antonio, Texas, was again transformed into the world’s capital in the fight against breast cancer. The 2012 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) was a joint presentation of the Cancer Therapy & Research Center at the University of Texas Health Science Center at San Antonio, the American Association for Cancer Research, and the Baylor College of Medicine. This years’ meeting drew nearly 8,000 participants from over 90 countries and again proved to be the number one breast cancer meeting in the world. This report does not aim to summarise the entire meeting but discusses the key highlights of the meeting.
(BELG J MED ONCOL 2013;7:31–33)
Read more
Top
